Parents' Experiences with Home-Based Oral Chemotherapy Prescribed to a Child Diagnosed with Acute Lymphoblastic Leukemia: A Qualitative Study

• Published in: Current oncology (Toronto) 2021-11, Vol.28 (6), p.4377-4391
• Main Authors: Camiré-Bernier, Étienne, Nidelet, Erwan, Baghdadli, Amel, Demers, Gabriel, Boulanger, Marie-Christine, Brisson, Marie-Claude, Michon, Bruno, Lauzier, Sophie, Laverdière, Isabelle
• Format: Article
• Language: English
• Subjects: acute lymphoblastic leukemia; Adolescent; antineoplastic agents; cancer; Child; Humans; medication adherence; Parents - psychology; Patient Care Team; Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy; Qualitative Research
• ISSN: 1718-7729; 1198-0052; 1718-7729
• DOI: 10.3390/curroncol28060372

Acute lymphoblastic leukemia (ALL) is the most common type of cancer in children. Treatment includes home-based oral chemotherapies (OCs) (e.g., 6-mercaptopurine and dexamethasone) taken for 2 to 3 years. The management of OC can be challenging for children and their parents. However, the multifaceted experience of families with children taking OC for ALL is largely undescribed. We report the experience with these OCs from the parents' perspective. We conducted a qualitative descriptive study. Semi-structured interviews were conducted with the parents of children with ALL aged < 15 years, followed in a specialized university-affiliated center. The interviews were fully transcribed and thematically analyzed. Thirteen of the seventeen eligible parents (76.5%) participated in the study. The parents' motivation to follow the recommendations provided by the multidisciplinary care team regarding OC was very high. The quantity and the quality of the information received were judged adequate, and the parents reported feeling knowledgeable enough to take charge of the OC at home. Adapting to the consequences of OC on family daily life was collectively identified as the biggest challenge. This includes developing and maintaining a strict daily routine, adapting to the child's neurobehavioral changes during dexamethasone days and adapting family social life. Our findings have several implications for enhancing the support offered to families with home-based OC for ALL. Supportive interventions should consider the family as a whole and their needs should be regularly monitored. Specific attention should be paid to the development and maintenance of a routine, to the parental burden, and to the emotional impact, especially regarding dexamethasone.